Price:
Rs. 22,050.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes: G0103
Frequently Asked Questions (FAQ's):
What does the CYP21A2 Gene Panel test detect?
It identifies pathogenic variants in the CYP21A2 gene associated with 21-hydroxylase deficiency using NGS at Metropolis Healthcare.
Who should consider this test?
Newborns or children with ambiguous genitalia, electrolyte imbalances, or a family history of congenital adrenal hyperplasia.
What sample is required for this test?
EDTA blood is used for DNA extraction and sequencing.
How does Metropolis Healthcare perform this test?
Metropolis uses high-coverage NGS technology to accurately detect deletions, point mutations, and complex variants in CYP21A2.
Can this test guide treatment decisions?
Yes, identifying the mutation helps tailor hormone replacement therapy and monitor disease severity.
Is this test useful for carrier screening?
Yes, it can identify carriers in families planning pregnancies.
How long does it take to get results?
Results are typically available within a few working days depending on lab workflow at Metropolis Healthcare.
Is genetic counselling recommended?
Yes, counselling helps families understand inheritance patterns, recurrence risks, and prenatal planning options